- AI
- Molecular Imaging
- CT
- X-Ray
- Ultrasound
- MRI
- Facility Management
- Mammography
Future of imaging science depends on risk takers
Radiologists need to become great risk takers and follow clinical science's move toward systems biology or become irrelevant, according to Dr. Elias Zerhouni, director of the National Institutes of Health.
Radiologists need to become great risk takers and follow clinical science's move toward systems biology or become irrelevant, according to Dr. Elias Zerhouni, director of the National Institutes of Health.
Imagers need to replace the current imaging approach to understand complex disease mechanisms, such as inflammation or apoptosis, rather than simply specific conditions, like arthritis or cancer. That means moving down the angstrom scale to resolve complex macromolecular structures, Zerhouni said.
Radiologists should develop biomarkers to assist in the study of treatments for long-term chronic diseases and get involved in image-guided intervention and microsampling for disease characterization, he said.
Zerhouni spoke during a session on the future of biomedical imaging and imaging research at the European Congress of Radiology. The NIH will invest about $1 billion in 2007 in projects with non-U.S. partners.
AI Mammography Platform Shows Promising Results for Detecting Subclinical Breast Cancer
October 3rd 2024Mean artificial intelligence (AI) scoring for breasts developing cancer was double that of contralateral breasts at initial biennial screening and was 16 times higher at the third biennial screening, according to a study involving over 116,000 women with no prior history of breast cancer.
FDA Clears Software for Enhancing CCTA Assessment of Atherosclerosis
October 1st 2024Through analysis of coronary computed tomography angiography (CCTA) images, the PlaqueIQ software provides quantification and classification of atherosclerosis, a common cause of myocardial infarction (MI) and ischemic stroke.
